Case Study: 858 Therapeutics streamlines drug discovery from concept to clinic with CDD Vault

858 Therapeutics streamlines research with CDD Vault and 18,000+ ELN entries

858 Therapeutics, an oncology-focused biotechnology company, needed a comprehensive and user-friendly drug discovery informatics platform to support its internal scientists and global CRO partners. Their challenge was to find a solution that could manage compounds and assay data, enhance collaboration, and provide robust documentation to support intellectual property and IND preparation. They selected CDD Vault from Collaborative Drug Discovery to address these needs.

The solution implemented was the deployment of four specialized CDD Vaults to organize research from concept to clinic. This provided a centralized platform for compound registration, inventory tracking, and over 18,000 ELN entries, which streamlined collaboration with CROs and secured project data. The measurable impact for 858 Therapeutics included a clear, timestamped record for inventorship and IP protection, simplified data visualization and reporting, and a more efficient research process that eliminated the need for multiple disparate applications.

858 Therapeutics